Targeted inhibition of mitochondrial dysfunction via tetrahedral framework nucleic acid attenuates osteoarthritis progression

S. Xue; C. Zhang; C. Zhong; N. Li; Z. Li; J. Liu; C. Ding

Targeted inhibition of mitochondrial dysfunction via tetrahedral framework nucleic acid attenuates osteoarthritis progression

S. Xue
, C. Zhang
, C. Zhong
, N. Li
, Z. Li
, J. Liu
, C. Ding^*

^*Corresponding author for this work

Research output: Contribution to conference › Conference poster › peer-review

Original language	English
Pages	399-400
Number of pages	2
Publication status	Published - 4 May 2023
Event	World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2023, WCO-IOF-ESCEO 2023 - CCIB Congress Center, Barcelona, Spain Duration: 4 May 2023 → 7 May 2023 https://www.wco-iof-esceo.org/

Congress

Congress	World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2023, WCO-IOF-ESCEO 2023
Country/Territory	Spain
City	Barcelona
Period	4/05/23 → 7/05/23
Internet address	https://www.wco-iof-esceo.org/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@conference{d2fe25f535104d5f95f004b611764c21,

title = "Targeted inhibition of mitochondrial dysfunction via tetrahedral framework nucleic acid attenuates osteoarthritis progression",

author = "S. Xue and C. Zhang and C. Zhong and N. Li and Z. Li and J. Liu and C. Ding",

note = "Funding from the 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guang-dong-Hong Kong-Macau Joint Lab, No.2020B1212030006), Na-tional Natural Science Foundation of China（No.81974342).; World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2023, WCO-IOF-ESCEO 2023 ; Conference date: 04-05-2023 Through 07-05-2023",

year = "2023",

month = may,

day = "4",

language = "English",

pages = "399--400",

url = "https://www.wco-iof-esceo.org/",

}

Targeted inhibition of mitochondrial dysfunction via tetrahedral framework nucleic acid attenuates osteoarthritis progression. / Xue, S.; Zhang, C.; Zhong, C. et al.
2023. 399-400 Poster session presented at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2023, WCO-IOF-ESCEO 2023, Barcelona, Spain.

Research output: Contribution to conference › Conference poster › peer-review

TY - CONF

T1 - Targeted inhibition of mitochondrial dysfunction via tetrahedral framework nucleic acid attenuates osteoarthritis progression

AU - Xue, S.

AU - Zhang, C.

AU - Zhong, C.

AU - Li, N.

AU - Li, Z.

AU - Liu, J.

AU - Ding, C.

N1 - Funding from the 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guang-dong-Hong Kong-Macau Joint Lab, No.2020B1212030006), Na-tional Natural Science Foundation of China（No.81974342).

PY - 2023/5/4

Y1 - 2023/5/4

UR - https://www.wco-iof-esceo.org/sites/wco_23/download/WCO23-AbstractBook.pdf

M3 - Conference poster

SP - 399

EP - 400

T2 - World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2023, WCO-IOF-ESCEO 2023

Y2 - 4 May 2023 through 7 May 2023

ER -

Targeted inhibition of mitochondrial dysfunction via tetrahedral framework nucleic acid attenuates osteoarthritis progression

Congress

UN SDGs

Other files and links

Cite this